SANGAMO THERAPEUTICS, INC.

SGMO · NASDAQ

Biological Product (except Diagnostic) Manufacturing

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering.

ESG Scores

Overall ESG

4.1

Environmental

4.9

Social

4.0

Governance

7.1

Gender Diversity

Female Directors0.44439999999999996%

Female Executives0.19393939393939394%

CEO GenderMale

Market Data

Price$0.26-0.01 (-2.96%)

Market Cap$109M

P/E Ratio—

EPS$—

52W High$0.84

52W Low$0.21

Beta1.53